Eli Lilly and Company’s investigational drug, retatrutide, a groundbreaking triple hormone receptor agonist, has delivered an average weight loss of…
Read More

Eli Lilly and Company’s investigational drug, retatrutide, a groundbreaking triple hormone receptor agonist, has delivered an average weight loss of…
Read More
The German biotechnology firm BioNTech, a name synonymous with the rapid development of the world’s first widely authorized mRNA COVID-19…
Read More
A newly published multicenter clinical study is poised to redefine the landscape of clinical laboratory operations, signaling a transformative shift…
Read More
After a period of post-pandemic uncertainty and uneven growth, a closely monitored metric of biopharmaceutical research and development (R&D) productivity…
Read More
In a landmark decision poised to reshape the pharmaceutical landscape and significantly impact patient access and healthcare costs, Health Canada…
Read More
The biotechnology sector is experiencing a significant resurgence, marked by a robust recovery in public markets and an explosion in…
Read More
In a significant development for neurodegenerative disease research, 28bio, a biotechnology firm based in Los Angeles, USA, has announced the…
Read More
BD (Becton, Dickinson and Company), a leading global medical technology company, has announced a strategic partnership with Wellstar Health System,…
Read More
Marty Makary resigned on Tuesday as commissioner of the Food and Drug Administration, effective immediately, following escalating rumors that President…
Read More
The landscape of lung cancer treatment has undergone a significant transformation with the advent of immunotherapy, particularly checkpoint inhibitors, offering…
Read More